210 related articles for article (PubMed ID: 17006610)
21. Ten-year survival of esophageal cancer after an en-bloc esophagectomy.
Oezcelik A; Kaiser GM; Niebel W; Sleyman C; Treckmann JW; Sotiropoulos GC; Reinhardt R; Trarbach T; Malamutmann E; Paul A
J Surg Oncol; 2012 Mar; 105(3):284-7. PubMed ID: 21953648
[TBL] [Abstract][Full Text] [Related]
22. Influence of Neoadjuvant Radiation Dose on Patients Undergoing Esophagectomy and Survival in Locally Advanced Esophageal Cancer.
Ising MS; Marino K; Trivedi JR; Rojan AA; Dunlap NE; van Berkel V; Fox MP
J Gastrointest Surg; 2019 Apr; 23(4):670-678. PubMed ID: 30788714
[TBL] [Abstract][Full Text] [Related]
23. Impact of patient selection, disease progression, and adverse events on esophageal cancer outcomes after trimodality therapy.
Gilbert S; Gresham GK; Jonker DJ; Seely AJ; Maziak DE; Shamji FM; Pantarotto J; Sundaresan S
Ann Thorac Surg; 2012 Nov; 94(5):1659-66. PubMed ID: 22981444
[TBL] [Abstract][Full Text] [Related]
24. Surgical complications and long-term survival after esophagectomy for cancer in a nationwide Swedish cohort study.
Rutegård M; Lagergren P; Rouvelas I; Mason R; Lagergren J
Eur J Surg Oncol; 2012 Jul; 38(7):555-61. PubMed ID: 22483704
[TBL] [Abstract][Full Text] [Related]
25. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma.
Cao XF; He XT; Ji L; Xiao J; Lv J
Dis Esophagus; 2009; 22(6):477-81. PubMed ID: 19703071
[TBL] [Abstract][Full Text] [Related]
26. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.
Visser E; Leeftink AG; van Rossum PS; Siesling S; van Hillegersberg R; Ruurda JP
Ann Surg Oncol; 2016 Aug; 23(8):2679-89. PubMed ID: 27012988
[TBL] [Abstract][Full Text] [Related]
27. [Esophagectomy as therapeutic principle for squamous cell esophageal cancer].
Siewert JR; Feith M; Stein HJ
Chirurg; 2005 Nov; 76(11):1033-43. PubMed ID: 16228234
[TBL] [Abstract][Full Text] [Related]
28. Surgical resection with and without chemotherapy in oesophageal cancer.
Bosset JF; Mercier M; Triboulet JP; Conroy T; Seitz JF
Lancet; 2002 Oct; 360(9340):1173-4; author reply 1175. PubMed ID: 12387978
[No Abstract] [Full Text] [Related]
29. [Principles of neoadjuvant therapy].
Lordick F
Chirurg; 2009 Nov; 80(11):1000-5. PubMed ID: 19812908
[TBL] [Abstract][Full Text] [Related]
30. Time shift in early postoperative mortality after oesophagectomy for cancer.
Rutegård M; Lagergren P; Johar A; Lagergren J
Ann Surg Oncol; 2015 Sep; 22(9):3144-9. PubMed ID: 25649859
[TBL] [Abstract][Full Text] [Related]
31. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
32. Does neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer?
Raja SG; Salhiyyah K; Nagarajan K
Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):661-4. PubMed ID: 17670718
[TBL] [Abstract][Full Text] [Related]
33. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.
Kim MP; Correa AM; Lee J; Rice DC; Roth JA; Mehran RJ; Walsh GL; Ajani JA; Maru DM; Chang JY; Marom EM; Macapinlac HA; Lee JH; Vaporciyan AA; Rice T; Swisher SG; Hofstetter WL
Ann Thorac Surg; 2010 Sep; 90(3):884-90; discussion 890-1. PubMed ID: 20732513
[TBL] [Abstract][Full Text] [Related]
34. Surgical resection with and without chemotherapy in oesophageal cancer.
Maraveyas A; O'Boyle C; Cowen M
Lancet; 2002 Oct; 360(9340):1174-5; author reply 1175. PubMed ID: 12387981
[No Abstract] [Full Text] [Related]
35. A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma.
Zahoor H; Luketich JD; Levy RM; Awais O; Winger DG; Gibson MK; Nason KS
J Thorac Cardiovasc Surg; 2015 Feb; 149(2):538-47. PubMed ID: 25454907
[TBL] [Abstract][Full Text] [Related]
36. [Multimodality therapy concepts in esophageal carcinoma].
Siewert JR; Ott K
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():39-43. PubMed ID: 11824282
[TBL] [Abstract][Full Text] [Related]
37. Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer.
Stiles BM; Christos P; Port JL; Lee PC; Paul S; Saunders J; Altorki NK
J Thorac Cardiovasc Surg; 2010 Feb; 139(2):387-94. PubMed ID: 20006355
[TBL] [Abstract][Full Text] [Related]
38. Neoadjuvant treatment response in negative nodes is an important prognosticator after esophagectomy.
Nieman DR; Peyre CG; Watson TJ; Cao W; Lunt MD; Lada MJ; Han MS; Jones CE; Peters JH
Ann Thorac Surg; 2015 Jan; 99(1):277-83. PubMed ID: 25442991
[TBL] [Abstract][Full Text] [Related]
39. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
40. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA
J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
